Martine van Vugt

Director/Board Member bij SCANDION ONCOLOGY A/S

71 jaar

Health Technology

Consumer Services

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Johnny Stilou	M	57	SCANDION ONCOLOGY A/S	3 jaar
Jan van de Winkel	M	63	GENMAB A/S	25 jaar
Deirdre Connelly	F	63	GENMAB A/S	7 jaar
Martin Møller	M	49	SCANDION ONCOLOGY A/S	3 jaar
Jørgen Vilhelm Bardenfleth	M	69	SCANDION ONCOLOGY A/S	6 jaar
Tahamtan Ahmadi	M	51	GENMAB A/S	7 jaar
Keld Flintholm Jørgensen	M	53	SCANDION ONCOLOGY A/S	2 jaar
Peter Michael Vestlev	M	-	SCANDION ONCOLOGY A/S	-
Jan Stenvang	M	-	SCANDION ONCOLOGY A/S	7 jaar
Anthony Pagano	M	46	GENMAB A/S	17 jaar
Susan Coles	F	58	TME PHARMA N.V.	3 jaar
Paolo Augusto Paoletti	M	73	GENMAB A/S	9 jaar
Pernille Erenbjerg	F	57	GENMAB A/S	9 jaar
Marisol Peron	F	-	GENMAB A/S	5 jaar
Maarten Ligtenberg	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Elizabeth O'Farrell	F	59	GENMAB A/S	2 jaar
Maurizio PetitBon	M	76	TME PHARMA N.V.	8 jaar
Karen Ophoff	F	-	TME PHARMA N.V.	23 jaar
Alejandra Maria Mørk	M	63	SCANDION ONCOLOGY A/S	2 jaar
Cornelis Alexander Izeboud	M	53	TME PHARMA N.V.	4 jaar
Rolf K. Hoffmann	M	64	GENMAB A/S	8 jaar
Aram Andrew Mangasarian	M	54	TME PHARMA N.V.	14 jaar
Ewelina Staniuk	F	-	TME PHARMA N.V.	6 jaar
Nicky Vogels	F	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Takahiro Hamatani	M	50	GENMAB A/S	2 jaar
Martin Schultz	M	49	GENMAB A/S	2 jaar
Heike Balzer	M	-	TME PHARMA N.V.	24 jaar
Christopher Cozic	M	46	GENMAB A/S	-
Allard Kaptein	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Anthony Mancini	M	53	GENMAB A/S	4 jaar
Mijke Zachariasse	M	51	GENMAB A/S	5 jaar
Morten Nissen	M	-	SCANDION ONCOLOGY A/S	-
Judith Klimovsky	M	67	GENMAB A/S	7 jaar
Shobhit Dhawan	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Birgitte Stephensen	F	63	GENMAB A/S	22 jaar
Andrew Carlsen	M	-	GENMAB A/S	5 jaar
François Martelet	M	64	SCANDION ONCOLOGY A/S	1 jaar
Anders Gersel Pedersen	M	73	GENMAB A/S	21 jaar
Lars Damstrup	M	-	SCANDION ONCOLOGY A/S	1 jaar

Meer zien

Relatiegrafiek

Connectie in verschillende bedrijven

Oude connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Daniel John Bruno	M	45	GENMAB A/S	5 jaar
Bo Rode Hansen	M	-	SCANDION ONCOLOGY A/S	2 jaar
Michael Blair Widmer	M	76	GENMAB A/S	11 jaar
Mats Gunnar Pettersson	M	78	GENMAB A/S	7 jaar
Bo Kruse	M	52	GENMAB A/S	8 jaar
Christina Hahner	F	-	GENMAB A/S	-
Jonathan Peacock	M	66	GENMAB A/S	1 jaar
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	54	GENMAB A/S	-
Michael K. Bauer	M	60	GENMAB A/S	14 jaar
Helle Husted	F	-	GENMAB A/S	-
Rachel Curtis Gravesen	F	55	GENMAB A/S	8 jaar
Nils Aage Brünner	M	72	SCANDION ONCOLOGY A/S	-
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 jaar
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 jaar
Bertram Köhler	M	53	TME PHARMA N.V.	5 jaar
Lisa N. Drakeman	M	70	GENMAB A/S	11 jaar
Burt Malkiel	M	90	GENMAB A/S	11 jaar
Antonius Theodorus M Wilderbeek	M	74	GENMAB A/S	2 jaar
Maj Hedtjärn	M	-	SCANDION ONCOLOGY A/S	1 jaar
Joseph deBethizy	M	74	TME PHARMA N.V.	7 jaar
Eva Ehrnrooth	M	57	GENMAB A/S	2 jaar
Suba Krishnan	M	59	GENMAB A/S	1 jaar
Richard Gordon Hibbert	M	44	GENMAB A/S	3 jaar
Peter Storm Kristensen	M	49	GENMAB A/S	-
Rima Bawarsh Nassar	M	70	GENMAB A/S	-
Steen Lisby	M	60	GENMAB A/S	9 jaar
Joris Wilms	M	50	GENMAB A/S	2 jaar
Christian Vinding Thomsen	M	-	SCANDION ONCOLOGY A/S	5 jaar
Nicklas Lindland Roest	F	39	SCANDION ONCOLOGY A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 jaar
Irwin Lerner	M	93	GENMAB A/S	-
Alfredo Zurlo	M	-	SCANDION ONCOLOGY A/S	-
Rikke Glahn Ren	F	-	GENMAB A/S	-
Barry Littlejohns	M	58	GENMAB A/S	-
Hanne Damgaard Jensen	F	-	GENMAB A/S	8 jaar
Paul W. H. I. Parren	M	60	GENMAB A/S	16 jaar
Annarie Lyles	M	63	GENMAB A/S	-
David Andrew Eatwell	M	63	GENMAB A/S	12 jaar
Joseph Fred Yospe	M	66	GENMAB A/S	2 jaar
Michael Wolff Jensen	M	53	GENMAB A/S	3 jaar
Claus Juan Møller-San Pedro	M	62	GENMAB A/S	9 jaar
Ernst H. Schweizer	M	-	GENMAB A/S	-
Bryan Jennings	M	-	TME PHARMA N.V.	1 jaar
Gregory Weaver	M	68	TME PHARMA N.V.	1 jaar
Mads Aaboe Jensen	M	-	SCANDION ONCOLOGY A/S	-

Statistieken

Land	Connecties	% van het totaal
Denemarken	71	82.56%
Duitsland	11	12.79%
Nederland	4	4.65%

Ouderdom van de connecties

Actief

Verleden

Man

Vrouw

Besturend

Uitvoerend

Oorsprong van de connecties

Beurs
Insiders
Martine van Vugt
Persoonlijk netwerk